Martin Raditsch is a graduate of Heidelberg University (Biochemistry) and holds a Ph.D. in Molecular Biology.
Following his Ph.D., Martin was Laboratory Leader in the pharmaceutical R&D division of BASF AG. After positions in product marketing in the agrochemical sector of the corporation and plant biotech project management, he became Head of Technology Management and was responsible for the applied technology portfolio of the plant biotech entity.
In July 2001 Martin joined EMBL Enterprise Management Technology Transfer GmbH (EMBLEM) (www.embl-em.de), a fully owned subsidiary of the European Molecular Biology Laboratory (EMBL) (www.embl.de) as Head of Business Development responsible for the commercialisation of intellectual property developed in the EMBL-world. As of January 2004 he is Deputy Managing Director of EMBLEM.
Martin is an alumnus of the Max-Planck-Society and a member of several professional societies such as LES and AUTM.
